Alpha Packaging Expands HDPE Manufacturing Platform on the East Coast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Alpha Packaging Expands HDPE Manufacturing Platform on the East Coast



Alpha Packaging has qualified six new injection blow molded high-density polyethylene (HDPE) packers as part of its new HDPE Pharma Line. When completed later this fall, Alpha’s Pharma Line will consist of more than a dozen injection blow molded and extrusion blow molded bottles that replicate the HDPE round bottles most prevalent in the pharmaceutical industry. The new line will also contribute to Alpha’s core customer base of nutritional supplement manufacturers and fillers, many of which are located near the company’s Bethlehem, Pa., manufacturing site.

Alpha is investing in new IBM and EBM machines and new molds for more than a dozen sizes of bottles, ranging from 50 cc to 950 cc. Sizes up to 300 cc will be manufactured on new equipment using the injection blow molding process. Larger sizes will be extrusion blow molded on new equipment with new blow molds.

Source: Alpha Packaging

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here